| Pamelor (Nortriptyline HCl) Drug Information: Description, User ... Learn about the prescription medication Pamelor (Nortriptyline HCl), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| PAMELOR - Bula PAMELOR - MedicinaNET PAMELOR - Bula PAMELOR com posologia, indicações, efeitos colaterais, interações e outras informações. Bulas de Medicamentos - Bulário de Remédios Comerciais ... Read More |
| Nortriptyline - Wikipedia, the free encyclopedia Nortriptyline is a second-generation tricyclic antidepressant (TCA) marketed as the hydrochloride salt under the trade names Sensoval, Aventyl, Pamelor, Norpress ... Read More |
| Pamelor O que é ? O princípio ativo do pamelor é a nortriptilina, um antidepressivo tricíclico, um dos primeiros grupos e portanto dos mais antigos e estudados tipos de ... Read More |
| Pamelor (nortriptyline) medical facts from Drugs.com Physician reviewed Pamelor patient information - includes Pamelor description, dosage and directions. Read More |
| Pamelor Pamelor . Cloridrato de nortriptilina. Uso adulto. Formas farmacêuticas e apresentações - Cápsulas: Embalagens com 20 cápsulas de 10 mg, 25 mg, 50 mg e 75 mg ... Read More |
| Pamelor | Define Pamelor at Dictionary.com pamelor noun a tricyclic antidepressant drug (trade name Pamelor) used along with psychotherapy to treat dysthymic depression; may interact dangerously if taken with ... Read More |
| Pamelor Official FDA information, side effects and uses. Accurate, FDA approved Pamelor information for healthcare professionals and patients - brought to you by Drugs.com. Read More |
| Pamelor - Bulário Bula de PAMELOR com efeitos colaterais e indicações do medicamento. Antidepressivos. PAMELOR é indicado para alívio dos sintomas de depressão. Depressões ... Read More |
| Pamelor Oral : Uses, Side Effects, Interactions, Pictures ... Find patient medical information for Pamelor Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Read More |
